BIIB Related Hot FDA News
-
Biogen Idec (BIIB) TECFIDERA gets positive opinion from EMA.
-
Biogen Idec (BIIB) Sinks 8% After ALS Drug Fails, Development Stopped
-
Biogen Idec (BIIB) Says EMPOWER Missed Primary Endpoint
-
Biogen (BIIB) Rallying 20% in Pre-Market as Results from BG-12 MS Pill Trial Very Strong
Back to BIIB Stock Lookup
